1887

Abstract

Almost 30 years after its initial discovery, infection with the human immunodeficiency virus-1 (HIV-1) remains incurable and the virus persists due to reservoirs of latently infected CD4 memory T-cells and sanctuary sites within the infected individual where drug penetration is poor. Reactivating latent viruses has been a key strategy to completely eliminate the virus from the host, but many difficulties and unanswered questions remain. In this review, the latest developments in HIV-persistence and latency research are presented.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.049296-0
2013-05-01
2019-12-05
Loading full text...

Full text loading...

/deliver/fulltext/jgv/94/5/917.html?itemId=/content/journal/jgv/10.1099/vir.0.049296-0&mimeType=html&fmt=ahah

References

  1. Ackley C. D. , Yamamoto J. K. , Levy N. , Pedersen N. C. , Cooper M. D. . ( 1990; ). Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. . J Virol 64:, 5652–5655.[PubMed]
    [Google Scholar]
  2. Alexaki A. , Wigdahl B. . ( 2008; ). HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination. . PLoS Pathog 4:, e1000215. [CrossRef] [PubMed]
    [Google Scholar]
  3. Allers K. , Hütter G. , Hofmann J. , Loddenkemper C. , Rieger K. , Thiel E. , Schneider T. . ( 2011; ). Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation. . Blood 117:, 2791–2799. [CrossRef] [PubMed]
    [Google Scholar]
  4. Anderson J. , Li M.-J. , Palmer B. , Remling L. , Li S. , Yam P. , Yee J.-K. , Rossi J. , Zaia J. , Akkina R. . ( 2007; ). Safety and efficacy of a lentiviral vector containing three anti-HIV genes–CCR5 ribozyme, tat-rev siRNA, and TAR decoy–in SCID-hu mouse-derived T cells. . Mol Ther 15:, 1182–1188.[PubMed] [CrossRef]
    [Google Scholar]
  5. Archin N. M. , Espeseth A. , Parker D. , Cheema M. , Hazuda D. , Margolis D. M. . ( 2009; ). Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. . AIDS Res Hum Retroviruses 25:, 207–212. [CrossRef] [PubMed]
    [Google Scholar]
  6. Archin N. M. , Liberty A. L. , Kashuba A. D. , Choudhary S. K. , Kuruc J. D. , Crooks A. M. , Parker D. C. , Anderson E. M. , Kearney M. F. . & other authors ( 2012; ). Administration of Vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. . Nature 487:, 482–485. [CrossRef] [PubMed]
    [Google Scholar]
  7. Assogba B. D. , Leavell S. , Porter K. , Burkhard M. J. . ( 2007; ). Mucosal administration of low-dose cell-associated feline immunodeficiency virus promotes viral latency. . J Infect Dis 195:, 1184–1188. [CrossRef] [PubMed]
    [Google Scholar]
  8. Bai J. , Gorantla S. , Banda N. , Cagnon L. , Rossi J. , Akkina R. . ( 2000; ). Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo . . Mol Ther 1:, 244–254. [CrossRef] [PubMed]
    [Google Scholar]
  9. Bailey J. R. , Sedaghat A. R. , Kieffer T. , Brennan T. , Lee P. K. , Wind-Rotolo M. , Haggerty C. M. , Kamireddi A. R. , Liu Y. . & other authors ( 2006; ). Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. . J Virol 80:, 6441–6457. [CrossRef] [PubMed]
    [Google Scholar]
  10. Baldauf H. M. , Pan X. , Erikson E. , Schmidt S. , Daddacha W. , Burggraf M. , Schenkova K. , Ambiel I. , Wabnitz G. . & other authors ( 2012; ). SAMHD1 restricts HIV-1 infection in resting CD4+ T cells. . Nat Med 18:, 1682–1689. [CrossRef] [PubMed]
    [Google Scholar]
  11. Banerjee C. , Archin N. , Michaels D. , Belkina A. C. , Denis G. V. , Bradner J. , Sebastiani P. , Margolis D. M. , Montano M. . ( 2012; ). BET bromodomain inhibition as a novel strategy for reactivation of HIV-1. . J Leukoc Biol 92:, 1147–1154. [CrossRef] [PubMed]
    [Google Scholar]
  12. Barlough J. E. , Ackley C. D. , George J. W. , Levy N. , Acevedo R. , Moore P. F. , Rideout B. A. , Cooper M. D. , Pedersen N. C. . ( 1991; ). Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. . J Acquir Immune Defic Syndr 4:, 219–227.[PubMed]
    [Google Scholar]
  13. Beatty J. A. , Willett B. J. , Gault E. A. , Jarrett O. . ( 1996; ). A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction. . J Virol 70:, 6199–6206.[PubMed]
    [Google Scholar]
  14. Bebenek K. , Abbotts J. , Wilson S. H. , Kunkel T. A. . ( 1993; ). Error-prone polymerization by HIV-1 reverse transcriptase. Contribution of template-primer misalignment, miscoding, and termination probability to mutational hot spots. . J Biol Chem 268:, 10324–10334.[PubMed]
    [Google Scholar]
  15. Benkirane M. , Chun R. F. , Xiao H. , Ogryzko V. V. , Howard B. H. , Nakatani Y. , Jeang K. T. . ( 1998; ). Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. . J Biol Chem 273:, 24898–24905. [CrossRef] [PubMed]
    [Google Scholar]
  16. Berard M. , Tough D. F. . ( 2002; ). Qualitative differences between naïve and memory T cells. . Immunology 106:, 127–138. [CrossRef] [PubMed]
    [Google Scholar]
  17. Best B. M. , Letendre S. L. , Koopmans P. , Rossi S. S. , Clifford D. B. , Collier A. C. , Gelman B. B. , Marra C. M. , McArthur J. C. . & other authors ( 2012; ). Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir. . J Acquir Immune Defic Syndr 59:, 376–381. [CrossRef] [PubMed]
    [Google Scholar]
  18. Biancotto A. , Grivel J.-C. , Gondois-Rey F. , Bettendroffer L. , Vigne R. , Brown S. , Margolis L. B. , Hirsch I. . ( 2004; ). Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue. . J Virol 78:, 10507–10515. [CrossRef] [PubMed]
    [Google Scholar]
  19. Blazkova J. , Trejbalova K. , Gondois-Rey F. , Halfon P. , Philibert P. , Guiguen A. , Verdin E. , Olive D. , Van Lint C. . & other authors ( 2009; ). CpG methylation controls reactivation of HIV from latency. . PLoS Pathog 5:, e1000554. [CrossRef] [PubMed]
    [Google Scholar]
  20. Bleul C. C. , Wu L. J. , Hoxie J. A. , Springer T. A. , Mackay C. R. . ( 1997; ). The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. . Proc Natl Acad Sci U S A 94:, 1925–1930. [CrossRef] [PubMed]
    [Google Scholar]
  21. Boberg A. , Bråve A. , Johansson S. , Wahren B. , Hinkula J. , Rollman E. . ( 2008; ). Murine models for HIV vaccination and challenge. . Expert Rev Vaccines 7:, 117–130. [CrossRef] [PubMed]
    [Google Scholar]
  22. Bosque A. , Planelles V. . ( 2009; ). Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. . Blood 113:, 58–65. [CrossRef] [PubMed]
    [Google Scholar]
  23. Bosque A. , Famiglietti M. , Weyrich A. S. , Goulston C. , Planelles V. . ( 2011; ). Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells. . PLoS Pathog 7:, e1002288. [CrossRef] [PubMed]
    [Google Scholar]
  24. Brenchley J. M. , Paiardini M. . ( 2011; ). Immunodeficiency lentiviral infections in natural and non-natural hosts. . Blood 118:, 847–854. [CrossRef] [PubMed]
    [Google Scholar]
  25. Brenchley J. M. , Schacker T. W. , Ruff L. E. , Price D. A. , Taylor J. H. , Beilman G. J. , Nguyen P. L. , Khoruts A. , Larson M. . & other authors ( 2004a; ). CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. . J Exp Med 200:, 749–759. [CrossRef] [PubMed]
    [Google Scholar]
  26. Brenchley J. M. , Hill B. J. , Ambrozak D. R. , Price D. A. , Guenaga F. J. , Casazza J. P. , Kuruppu J. , Yazdani J. , Migueles S. A. . & other authors ( 2004b; ). T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. . J Virol 78:, 1160–1168. [CrossRef] [PubMed]
    [Google Scholar]
  27. Brennan T. P. , Woods J. O. , Sedaghat A. R. , Siliciano J. D. , Siliciano R. F. , Wilke C. O. . ( 2009; ). Analysis of human immunodeficiency virus type 1 viremia and provirus in resting CD4+ T cells reveals a novel source of residual viremia in patients on antiretroviral therapy. . J Virol 83:, 8470–8481. [CrossRef] [PubMed]
    [Google Scholar]
  28. Brooks D. G. , Kitchen S. G. , Kitchen C. M. R. , Scripture-Adams D. D. , Zack J. A. . ( 2001; ). Generation of HIV latency during thymopoiesis. . Nat Med 7:, 459–464. [CrossRef] [PubMed]
    [Google Scholar]
  29. Bukrinsky M. I. , Stanwick T. L. , Dempsey M. P. , Stevenson M. . ( 1991; ). Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. . Science 254:, 423–427. [CrossRef] [PubMed]
    [Google Scholar]
  30. Burke B. , Brown H. J. , Marsden M. D. , Bristol G. , Vatakis D. N. , Zack J. A. . ( 2007; ). Primary cell model for activation-inducible human immunodeficiency virus. . J Virol 81:, 7424–7434. [CrossRef] [PubMed]
    [Google Scholar]
  31. Burnett J. C. , Rossi J. J. . ( 2012; ). RNA-based therapeutics: current progress and future prospects. . Chem Biol 19:, 60–71. [CrossRef] [PubMed]
    [Google Scholar]
  32. Burnett J. C. , Lim K. I. , Calafi A. , Rossi J. J. , Schaffer D. V. , Arkin A. P. . ( 2010; ). Combinatorial latency reactivation for HIV-1 subtypes and variants. . J Virol 84:, 5958–5974. [CrossRef] [PubMed]
    [Google Scholar]
  33. Buzón M. J. , Massanella M. , Llibre J. M. , Esteve A. , Dahl V. , Puertas M. C. , Gatell J. M. , Domingo P. , Paredes R. . & other authors ( 2010; ). HIV-1 replication and immune dynamics are affected by Raltegravir intensification of HAART-suppressed subjects. . Nat Med 16:, 460–465. [CrossRef] [PubMed]
    [Google Scholar]
  34. Cabrita G. J. M. , Ferreira B. S. , da Silva C. L. , Gonçalves R. , Almeida-Porada G. , Cabral J. M. S. . ( 2003; ). Hematopoietic stem cells: from the bone to the bioreactor. . Trends Biotechnol 21:, 233–240. [CrossRef] [PubMed]
    [Google Scholar]
  35. Canestri A. , Lescure F.-X. , Jaureguiberry S. , Moulignier A. , Amiel C. , Marcelin A. G. , Peytavin G. , Tubiana R. , Pialoux G. , Katlama C. . ( 2010; ). Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. . Clin Infect Dis 50:, 773–778. [CrossRef] [PubMed]
    [Google Scholar]
  36. Carter C. C. , Onafuwa-Nuga A. , McNamara L. A. , Riddell J. IV , Bixby D. , Savona M. R. , Collins K. L. . ( 2010; ). HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. . Nat Med 16:, 446–451. [CrossRef] [PubMed]
    [Google Scholar]
  37. Carter C. C. , McNamara L. A. , Onafuwa-Nuga A. , Shackleton M. , Riddell J. IV , Bixby D. , Savona M. R. , Morrison S. J. , Collins K. L. . ( 2011; ). HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells. . Cell Host Microbe 9:, 223–234. [CrossRef] [PubMed]
    [Google Scholar]
  38. Chahroudi A. , Bosinger S. E. , Vanderford T. H. , Paiardini M. , Silvestri G. . ( 2012; ). Natural SIV hosts: showing AIDS the door. . Science 335:, 1188–1193. [CrossRef] [PubMed]
    [Google Scholar]
  39. Chan C. N. , McMonagle E. L. , Hosie M. J. , Willett B. J. . ( 2013; ). Prostratin exhibits both replication enhancing and inhibiting effects on FIV infection of feline CD4+ T-cells. . Virus Res. 171:, 121–128. [CrossRef] [PubMed]
    [Google Scholar]
  40. Chen L. F. , Mu Y. , Greene W. C. . ( 2002; ). Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB. . EMBO J 21:, 6539–6548. [CrossRef] [PubMed]
    [Google Scholar]
  41. Chiang K. , Rice A. P. . ( 2012; ). MicroRNA-mediated restriction of HIV-1 in resting CD4+ T cells and monocytes. . Viruses 4:, 1390–1409. [CrossRef] [PubMed]
    [Google Scholar]
  42. Choe H. , Farzan M. , Sun Y. , Sullivan N. , Rollins B. , Ponath P. D. , Wu L. , Mackay C. R. , LaRosa G. . & other authors ( 1996; ). The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. . Cell 85:, 1135–1148. [CrossRef] [PubMed]
    [Google Scholar]
  43. Chomont N. , El-Far M. , Ancuta P. , Trautmann L. , Procopio F. A. , Yassine-Diab B. , Boucher G. , Boulassel M.-R. , Ghattas G. . & other authors ( 2009; ). HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. . Nat Med 15:, 893–900. [CrossRef] [PubMed]
    [Google Scholar]
  44. Choudhary S. K. , Rezk N. L. , Ince W. L. , Cheema M. , Zhang L. , Su L. , Swanstrom R. , Kashuba A. D. , Margolis D. M. . ( 2009; ). Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2–/–γc–/– mouse. . J Virol 83:, 8254–8258. [CrossRef] [PubMed]
    [Google Scholar]
  45. Choudhary S. K. , Archin N. M. , Cheema M. , Dahl N. P. , Garcia J. V. , Margolis D. M. . ( 2012; ). Latent HIV-1 infection of resting CD4+ T cells in the humanized Rag2−/− γc−/− mouse. . J Virol 86:, 114–120. [CrossRef] [PubMed]
    [Google Scholar]
  46. Chun T. W. , Finzi D. , Margolick J. , Chadwick K. , Schwartz D. , Siliciano R. F. . ( 1995; ). In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. . Nat Med 1:, 1284–1290. [CrossRef] [PubMed]
    [Google Scholar]
  47. Chun T. W. , Carruth L. , Finzi D. , Shen X. , DiGiuseppe J. A. , Taylor H. , Hermankova M. , Chadwick K. , Margolick J. . & other authors ( 1997; ). Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. . Nature 387:, 183–188. [CrossRef] [PubMed]
    [Google Scholar]
  48. Chun T. W. , Engel D. , Mizell S. B. , Ehler L. A. , Fauci A. S. . ( 1998; ). Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines. . J Exp Med 188:, 83–91. [CrossRef] [PubMed]
    [Google Scholar]
  49. Chun T. W. , Davey R. T. Jr , Engel D. , Lane H. C. , Fauci A. S. . ( 1999; ). Re-emergence of HIV after stopping therapy. . Nature 401:, 874–875. [CrossRef] [PubMed]
    [Google Scholar]
  50. Chun T. W. , Nickle D. C. , Justement J. S. , Large D. , Semerjian A. , Curlin M. E. , O’Shea M. A. , Hallahan C. W. , Daucher M. . & other authors ( 2005; ). HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. . J Clin Invest 115:, 3250–3255. [CrossRef] [PubMed]
    [Google Scholar]
  51. Chun T.-W. , Nickle D. C. , Justement J. S. , Meyers J. H. , Roby G. , Hallahan C. W. , Kottilil S. , Moir S. , Mican J. M. . & other authors ( 2008; ). Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. . J Infect Dis 197:, 714–720. [CrossRef] [PubMed]
    [Google Scholar]
  52. Churchill M. J. , Gorry P. R. , Cowley D. , Lal L. , Sonza S. , Purcell D. F. J. , Thompson K. A. , Gabuzda D. , McArthur J. C. . & other authors ( 2006; ). Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues. . J Neurovirol 12:, 146–152. [CrossRef] [PubMed]
    [Google Scholar]
  53. Cicala C. , Arthos J. , Censoplano N. , Cruz C. , Chung E. , Martinelli E. , Lempicki R. A. , Natarajan V. , VanRyk D. . & other authors ( 2006; ). HIV-1 gp120 induces NFAT nuclear translocation in resting CD4+ T-cells. . Virology 345:, 105–114. [CrossRef] [PubMed]
    [Google Scholar]
  54. Cillo A. , Krishnan A. , Mitsuyasu R. , McMahon D. , Li S. , Rossi J. , Zaia J. , Mellors J. W. . ( 2012; ). Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for AIDS-related lymphoma. . In CROI. Seattle, USA:.
    [Google Scholar]
  55. Coffer P. J. , Burgering B. M. . ( 2004; ). Forkhead-box transcription factors and their role in the immune system. . Nat Rev Immunol 4:, 889–899. [CrossRef] [PubMed]
    [Google Scholar]
  56. Coiras M. , López-Huertas M. R. , Pérez-Olmeda M. , Alcamí J. . ( 2009; ). Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. . Nat Rev Microbiol 7:, 798–812. [CrossRef] [PubMed]
    [Google Scholar]
  57. Coleman C. M. , Wu L. . ( 2009; ). HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. . Retrovirology 6:, 51. [CrossRef] [PubMed]
    [Google Scholar]
  58. Colin L. , Van Lint C. . ( 2009; ). Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies. . Retrovirology 6:, 111. [CrossRef] [PubMed]
    [Google Scholar]
  59. Connor R. I. , Sheridan K. E. , Ceradini D. , Choe S. , Landau N. R. . ( 1997; ). Change in coreceptor use correlates with disease progression in HIV-1–infected individuals. . J Exp Med 185:, 621–628. [CrossRef] [PubMed]
    [Google Scholar]
  60. Contreras X. , Schweneker M. , Chen C.-S. , McCune J. M. , Deeks S. G. , Martin J. , Peterlin B. M. . ( 2009; ). Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. . J Biol Chem 284:, 6782–6789. [CrossRef] [PubMed]
    [Google Scholar]
  61. Coull J. J. , Romerio F. , Sun J. M. , Volker J. L. , Galvin K. M. , Davie J. R. , Shi Y. , Hansen U. , Margolis D. M. . ( 2000; ). The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. . J Virol 74:, 6790–6799. [CrossRef] [PubMed]
    [Google Scholar]
  62. d’Arminio A. , Sabin C. A. , Phillips A. N. , Reiss P. , Weber R. , Kirk O. , El-Sadr W. , De Wit S. , Mateu S. . & other authors ( 2004; ). Cardio- and cerebrovascular events in HIV-infected persons. . AIDS 18:, 1811–1817. [CrossRef] [PubMed]
    [Google Scholar]
  63. Dalgleish A. G. , Beverley P. C. , Clapham P. R. , Crawford D. H. , Greaves M. F. , Weiss R. A. . ( 1984; ). The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. . Nature 312:, 763–767. [CrossRef] [PubMed]
    [Google Scholar]
  64. Davey R. T. Jr , Bhat N. , Yoder C. , Chun T. W. , Metcalf J. A. , Dewar R. , Natarajan V. , Lempicki R. A. , Adelsberger J. W. . & other authors ( 1999; ). HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. . Proc Natl Acad Sci U S A 96:, 15109–15114. [CrossRef] [PubMed]
    [Google Scholar]
  65. Davis B. R. , Schwartz D. H. , Marx J. C. , Johnson C. E. , Berry J. M. , Lyding J. , Merigan T. C. , Zander A. . ( 1991; ). Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo. . J Virol 65:, 1985–1990.[PubMed]
    [Google Scholar]
  66. Dean M. , Carrington M. , Winkler C. , Huttley G. A. , Smith M. W. , Allikmets R. , Goedert J. J. , Buchbinder S. P. , Vittinghoff E. . & other authors ( 1996; ). Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. . Science 273:, 1856–1862. [CrossRef] [PubMed]
    [Google Scholar]
  67. Deeks S. G. . ( 2011; ). HIV infection, inflammation, immunosenescence, and aging. . Annu Rev Med 62:, 141–155. . [CrossRef] [PubMed]
    [Google Scholar]
  68. Deeks S. G. , Autran B. , Berkhout B. , Benkirane M. , Cairns S. , Chomont N. , Chun T. W. , Churchill M. , Di Mascio M. . & other authors ( 2012; ). Towards an HIV cure: a global scientific strategy. . Nat Rev Immunol 12:, 607–614. [CrossRef] [PubMed]
    [Google Scholar]
  69. Deng H. , Liu R. , Ellmeier W. , Choe S. , Unutmaz D. , Burkhart M. , Di Marzio P. , Marmon S. , Sutton R. E. . & other authors ( 1996; ). Identification of a major co-receptor for primary isolates of HIV-1. . Nature 381:, 661–666. [CrossRef] [PubMed]
    [Google Scholar]
  70. Descours B. , Cribier A. , Chable-Bessia C. , Ayinde D. , Rice G. , Crow Y. , Yatim A. , Schwartz O. , Laguette N. , Benkirane M. . ( 2012; ). SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+ T-cells. . Retrovirology 9:, 87. [CrossRef] [PubMed]
    [Google Scholar]
  71. Di Mascio M. , Srinivasula S. , Bhattacharjee A. , Cheng L. , Martiniova L. , Herscovitch P. , Lertora J. , Kiesewetter D. . ( 2009; ). Antiretroviral tissue kinetics: in vivo imaging using positron emission tomography. . Antimicrob Agents Chemother 53:, 4086–4095. [CrossRef] [PubMed]
    [Google Scholar]
  72. Dinoso J. B. , Rabi S. A. , Blankson J. N. , Gama L. , Mankowski J. L. , Siliciano R. F. , Zink M. C. , Clements J. E. . ( 2009a; ). A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy. . J Virol 83:, 9247–9257. [CrossRef] [PubMed]
    [Google Scholar]
  73. Dinoso J. B. , Kim S. Y. , Wiegand A. M. , Palmer S. E. , Gange S. J. , Cranmer L. , O’Shea A. , Callender M. , Spivak A. . & other authors ( 2009b; ). Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. . Proc Natl Acad Sci U S A 106:, 9403–9408. [CrossRef] [PubMed]
    [Google Scholar]
  74. Douek D. C. , Roederer M. , Koup R. A. . ( 2009; ). Emerging concepts in the immunopathogenesis of AIDS. . Annu Rev Med 60:, 471–484. [CrossRef] [PubMed]
    [Google Scholar]
  75. Durand C. M. , Ghiaur G. , Siliciano J. D. , Rabi S. A. , Eisele E. E. , Salgado M. , Shan L. , Lai J. F. , Zhang H. . & other authors ( 2012; ). HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapy. . J Infect Dis 205:, 1014–1018. [CrossRef] [PubMed]
    [Google Scholar]
  76. Egberink H. F. , Keldermans C. E. , Koolen M. J. , Horzinek M. C. . ( 1992; ). Humoral immune response to feline immunodeficiency virus in cats with experimentally induced and naturally acquired infections. . Am J Vet Res 53:, 1133–1138.[PubMed]
    [Google Scholar]
  77. Eichbaum Q. . ( 2011; ). PD-1 signaling in HIV and chronic viral infection–potential for therapeutic intervention?. Curr Med Chem 18:, 3971–3980. [CrossRef] [PubMed]
    [Google Scholar]
  78. Eisele E. , Siliciano R. F. . ( 2012; ). Redefining the viral reservoirs that prevent HIV-1 eradication. . Immunity 37:, 377–388. [CrossRef] [PubMed]
    [Google Scholar]
  79. Else L. J. , Taylor S. , Back D. J. , Khoo S. H. . ( 2011; ). Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract. . Antivir Ther 16:, 1149–1167. [CrossRef] [PubMed]
    [Google Scholar]
  80. Feng Y. , Broder C. C. , Kennedy P. E. , Berger E. A. . ( 1996; ). HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. . Science 272:, 872–877. [CrossRef] [PubMed]
    [Google Scholar]
  81. Filippakopoulos P. , Qi J. , Picaud S. , Shen Y. , Smith W. B. , Fedorov O. , Morse E. M. , Keates T. , Hickman T. T. . & other authors ( 2010; ). Selective inhibition of BET bromodomains. . Nature 468:, 1067–1073. [CrossRef] [PubMed]
    [Google Scholar]
  82. Finzi D. , Hermankova M. , Pierson T. , Carruth L. M. , Buck C. , Chaisson R. E. , Quinn T. C. , Chadwick K. , Margolick J. . & other authors ( 1997; ). Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. . Science 278:, 1295–1300. [CrossRef] [PubMed]
    [Google Scholar]
  83. Flynn J. N. , Dunham S. , Mueller A. , Cannon C. , Jarrett O. . ( 2002; ). Involvement of cytolytic and non-cytolytic T cells in the control of feline immunodeficiency virus infection. . Vet Immunol Immunopathol 85:, 159–170. [CrossRef] [PubMed]
    [Google Scholar]
  84. Folks T. M. , Justement J. , Kinter A. , Dinarello C. A. , Fauci A. S. . ( 1987; ). Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. . Science 238:, 800–802. [CrossRef] [PubMed]
    [Google Scholar]
  85. Folks T. M. , Kessler S. W. , Orenstein J. M. , Justement J. S. , Jaffe E. S. , Fauci A. S. . ( 1988; ). Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. . Science 242:, 919–922. [CrossRef] [PubMed]
    [Google Scholar]
  86. Folks T. M. , Clouse K. A. , Justement J. , Rabson A. , Duh E. , Kehrl J. H. , Fauci A. S. . ( 1989; ). Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. . Proc Natl Acad Sci U S A 86:, 2365–2368. [CrossRef] [PubMed]
    [Google Scholar]
  87. Gabriel R. , Lombardo A. , Arens A. , Miller J. C. , Genovese P. , Kaeppel C. , Nowrouzi A. , Bartholomae C. C. , Wang J. . & other authors ( 2011; ). An unbiased genome-wide analysis of zinc-finger nuclease specificity. . Nat Biotechnol 29:, 816–823. [CrossRef] [PubMed]
    [Google Scholar]
  88. Gandhi R. T. , Zheng L. , Bosch R. J. , Chan E. S. , Margolis D. M. , Read S. , Kallungal B. , Palmer S. , Medvik K. . & other authors ( 2010; ). The effect of Raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial. . PLoS Med 7:, e1000321. [CrossRef] [PubMed]
    [Google Scholar]
  89. Gartner S. , Markovits P. , Markovitz D. M. , Kaplan M. H. , Gallo R. C. , Popovic M. . ( 1986; ). The role of mononuclear phagocytes in HTLV-III/LAV infection. . Science 233:, 215–219. [CrossRef] [PubMed]
    [Google Scholar]
  90. Ghose R. , Liou L. Y. , Herrmann C. H. , Rice A. P. . ( 2001; ). Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4+ T lymphocytes by combination of cytokines. . J Virol 75:, 11336–11343. [CrossRef] [PubMed]
    [Google Scholar]
  91. Goldman J. P. , Blundell M. P. , Lopes L. , Kinnon C. , Di Santo J. P. , Thrasher A. J. . ( 1998; ). Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. . Br J Haematol 103:, 335–342. [CrossRef] [PubMed]
    [Google Scholar]
  92. González-Scarano F. , Martín-García J. . ( 2005; ). The neuropathogenesis of AIDS. . Nat Rev Immunol 5:, 69–81. [CrossRef] [PubMed]
    [Google Scholar]
  93. Greger I. H. , Demarchi F. , Giacca M. , Proudfoot N. J. . ( 1998; ). Transcriptional interference perturbs the binding of Sp1 to the HIV-1 promoter. . Nucleic Acids Res 26:, 1294–1301. [CrossRef] [PubMed]
    [Google Scholar]
  94. Gutiérrez C. , Díaz L. , Vallejo A. , Hernández-Novoa B. , Abad M. , Madrid N. , Dahl V. , Rubio R. , Moreno A. M. . & other authors ( 2011; ). Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected. . PLoS ONE 6:, e27864. [CrossRef] [PubMed]
    [Google Scholar]
  95. Haaland R. E. , Yu W. , Rice A. P. . ( 2005; ). Identification of LKLF-regulated genes in quiescent CD4+ T lymphocytes. . Mol Immunol 42:, 627–641. [CrossRef] [PubMed]
    [Google Scholar]
  96. Halfon P. , Giorgetti C. , Khiri H. , Pénaranda G. , Terriou P. , Porcu-Buisson G. , Chabert-Orsini V. . ( 2010; ). Semen may harbor HIV despite effective HAART: another piece in the puzzle. . PLoS ONE 5:, e10569. [CrossRef] [PubMed]
    [Google Scholar]
  97. Han Y. , Lassen K. , Monie D. , Sedaghat A. R. , Shimoji S. , Liu X. , Pierson T. C. , Margolick J. B. , Siliciano R. F. , Siliciano J. D. . ( 2004; ). Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. . J Virol 78:, 6122–6133. [CrossRef] [PubMed]
    [Google Scholar]
  98. Han Y. , Wind-Rotolo M. , Yang H. C. , Siliciano J. D. , Siliciano R. F. . ( 2007; ). Experimental approaches to the study of HIV-1 latency. . Nat Rev Microbiol 5:, 95–106. [CrossRef] [PubMed]
    [Google Scholar]
  99. Han Y. , Lin Y. B. , An W. , Xu J. , Yang H. C. , O’Connell K. , Dordai D. , Boeke J. D. , Siliciano J. D. , Siliciano R. F. . ( 2008; ). Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. . Cell Host Microbe 4:, 134–146. [CrossRef] [PubMed]
    [Google Scholar]
  100. Hatano H. , Hayes T. L. , Dahl V. , Sinclair E. , Lee T. H. , Hoh R. , Lampiris H. , Hunt P. W. , Palmer S. . & other authors ( 2011; ). A randomized, controlled trial of Raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response. . J Infect Dis 203:, 960–968. [CrossRef] [PubMed]
    [Google Scholar]
  101. Hecht R. , Stover J. , Bollinger L. , Muhib F. , Case K. , de Ferranti D. . ( 2010; ). Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009-31. . Lancet 376:, 1254–1260. [CrossRef] [PubMed]
    [Google Scholar]
  102. Hermankova M. , Siliciano J. D. , Zhou Y. , Monie D. , Chadwick K. , Margolick J. B. , Quinn T. C. , Siliciano R. F. . ( 2003; ). Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo. . J Virol 77:, 7383–7392. [CrossRef] [PubMed]
    [Google Scholar]
  103. Hesselton R. M. , Greiner D. L. , Mordes J. P. , Rajan T. V. , Sullivan J. L. , Shultz L. D. . ( 1995; ). High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice. . J Infect Dis 172:, 974–982. [CrossRef] [PubMed]
    [Google Scholar]
  104. Hirsch V. M. , Fuerst T. R. , Sutter G. , Carroll M. W. , Yang L. C. , Goldstein S. , Piatak M. Jr , Elkins W. R. , Alvord W. G. . & other authors ( 1996; ). Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. . J Virol 70:, 3741–3752.[PubMed]
    [Google Scholar]
  105. Hirsch V. M. , Lifson J. D. , Kuah-Teh J. . ( 2000; ). Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention. . In Advances in Pharmacology, vol. 49, pp. 437–477. Academic Press;. [CrossRef]
    [Google Scholar]
  106. Ho D. D. , Rota T. R. , Hirsch M. S. . ( 1986; ). Infection of monocyte/macrophages by human T lymphotropic virus type III. . J Clin Invest 77:, 1712–1715. [CrossRef] [PubMed]
    [Google Scholar]
  107. Ho D. D. , Neumann A. U. , Perelson A. S. , Chen W. , Leonard J. M. , Markowitz M. . ( 1995; ). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. . Nature 373:, 123–126. [CrossRef] [PubMed]
    [Google Scholar]
  108. Holt N. , Wang J. , Kim K. , Friedman G. , Wang X. , Taupin V. , Crooks G. M. , Kohn D. B. , Gregory P. D. . & other authors ( 2010; ). Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. . Nat Biotechnol 28:, 839–847. [CrossRef] [PubMed]
    [Google Scholar]
  109. Hosie M. J. , Pajek D. , Samman A. , Willett B. J. . ( 2011; ). Feline immunodeficiency virus (FIV) neutralization: a review. . Viruses 3:, 1870–1890. [CrossRef] [PubMed]
    [Google Scholar]
  110. Howard K. E. , Reckling S. K. , Egan E. A. , Dean G. A. . ( 2010; ). Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats. . Retrovirology 7:, 2. [CrossRef] [PubMed]
    [Google Scholar]
  111. Hütter G. , Nowak D. , Mossner M. , Ganepola S. , Müssig A. , Allers K. , Schneider T. , Hofmann J. , Kücherer C. . & other authors ( 2009; ). Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. . N Engl J Med 360:, 692–698. [CrossRef] [PubMed]
    [Google Scholar]
  112. Joos B. , Fischer M. , Kuster H. , Pillai S. K. , Wong J. K. , Böni J. , Hirschel B. , Weber R. , Trkola A. , Günthard H. F. . Swiss HIV Cohort Study ( 2008; ). HIV rebounds from latently infected cells, rather than from continuing low-level replication. . Proc Natl Acad Sci U S A 105:, 16725–16730. [CrossRef] [PubMed]
    [Google Scholar]
  113. Jordan A. , Bisgrove D. , Verdin E. . ( 2003; ). HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. . EMBO J 22:, 1868–1877. [CrossRef] [PubMed]
    [Google Scholar]
  114. Josefsson L. , Eriksson S. , Sinclair E. , Ho T. , Killian M. , Epling L. , Shao W. , Lewis B. , Bacchetti P. . & other authors ( 2012; ). Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNA. . J Infect Dis 206:, 28–34. [CrossRef] [PubMed]
    [Google Scholar]
  115. Joshi A. , Vahlenkamp T. W. , Garg H. , Tompkins W. A. F. , Tompkins M. B. . ( 2004; ). Preferential replication of FIV in activated CD4+CD25+T cells independent of cellular proliferation. . Virology 321:, 307–322. [CrossRef] [PubMed]
    [Google Scholar]
  116. Joshi A. , Garg H. , Tompkins M. B. , Tompkins W. A. . ( 2005; ). Different thresholds of T cell activation regulate FIV infection of CD4+CD25+ and CD4+CD25- cells. . Virology 335:, 212–221. [CrossRef] [PubMed]
    [Google Scholar]
  117. June C. , Pablo T. , Stein D. , Mitsuyasu R. , Lalezari J. , Wang S. , Lee G. , Levine B. , Tang W. . & other authors ( 2012; ). Induction of acquired CCR5 deficiency with zinc finger nuclease-modified autologous CD4 T cells (SB-728-T) correlates with increases in CD4 count and effects on viral load in HIV-infected subjects. . In 19th Conference on Retroviruses and Opportunistic Infections (CROI).
  118. Kauder S. E. , Bosque A. , Lindqvist A. , Planelles V. , Verdin E. . ( 2009; ). Epigenetic regulation of HIV-1 latency by cytosine methylation. . PLoS Pathog 5:, e1000495. [CrossRef] [PubMed]
    [Google Scholar]
  119. Kerr J. S. , Galloway S. , Lagrutta A. , Armstrong M. , Miller T. , Richon V. M. , Andrews P. A. . ( 2010; ). Nonclinical safety assessment of the histone deacetylase inhibitor Vorinostat. . Int J Toxicol 29:, 3–19. [CrossRef] [PubMed]
    [Google Scholar]
  120. Kornfeld H. , Cruikshank W. W. , Pyle S. W. , Berman J. S. , Center D. M. . ( 1988; ). Lymphocyte activation by HIV-1 envelope glycoprotein. . Nature 335:, 445–448. [CrossRef] [PubMed]
    [Google Scholar]
  121. Kraase M. , Sloan R. , Klein D. , Logan N. , McMonagle L. , Biek R. , Willett B. J. , Hosie M. J. . ( 2010; ). Feline immunodeficiency virus env gene evolution in experimentally infected cats. . Vet Immunol Immunopathol 134:, 96–106. [CrossRef] [PubMed]
    [Google Scholar]
  122. Kulkosky J. , Culnan D. M. , Roman J. , Dornadula G. , Schnell M. , Boyd M. R. , Pomerantz R. J. . ( 2001; ). Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. . Blood 98:, 3006–3015. [CrossRef] [PubMed]
    [Google Scholar]
  123. Kumar P. , Ban H.-S. , Kim S.-S. , Wu H. , Pearson T. , Greiner D. L. , Laouar A. , Yao J. , Haridas V. . & other authors ( 2008; ). T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. . Cell 134:, 577–586. [CrossRef] [PubMed]
    [Google Scholar]
  124. Kwara A. , Delong A. , Rezk N. , Hogan J. , Burtwell H. , Chapman S. , Moreira C. C. , Kurpewski J. , Ingersoll J. . & other authors ( 2008; ). Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy. . Clin Infect Dis 46:, 719–725. [CrossRef] [PubMed]
    [Google Scholar]
  125. Kwon H. S. , Brent M. M. , Getachew R. , Jayakumar P. , Chen L. F. , Schnolzer M. , McBurney M. W. , Marmorstein R. , Greene W. C. , Ott M. . ( 2008; ). Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation. . Cell Host Microbe 3:, 158–167. [CrossRef] [PubMed]
    [Google Scholar]
  126. Lassen K. G. , Bailey J. R. , Siliciano R. F. . ( 2004; ). Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo. . J Virol 78:, 9105–9114. [CrossRef] [PubMed]
    [Google Scholar]
  127. Lassen K. G. , Ramyar K. X. , Bailey J. R. , Zhou Y. , Siliciano R. F. . ( 2006; ). Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells. . PLoS Pathog 2:, e68. [CrossRef] [PubMed]
    [Google Scholar]
  128. Launay O. , Tod M. , Tschöpe I. , Si-Mohamed A. , Bélarbi L. , Charpentier C. , Goujard C. , Taburet A. M. , Lortholary O. . & other authors ( 2011; ). Residual HIV-1 RNA and HIV-1 DNA production in the genital tract reservoir of women treated with HAART: the prospective ANRS EP24 GYNODYN study. . Antivir Ther 16:, 843–852. [CrossRef] [PubMed]
    [Google Scholar]
  129. Le Douce V. , Herbein G. , Rohr O. , Schwartz C. . ( 2010; ). Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage. . Retrovirology 7:, 32. [CrossRef] [PubMed]
    [Google Scholar]
  130. Levy Y. , Lacabaratz C. , Weiss L. , Viard J. P. , Goujard C. , Lelièvre J. D. , Boué F. , Molina J. M. , Rouzioux C. . & other authors ( 2009; ). Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. . J Clin Invest 119:, 997–1007.[PubMed]
    [Google Scholar]
  131. Levy Y. , Sereti I. , Tambussi G. , Routy J. P. , Lelievre J. D. , Delfraissy J. F. , Molina J. M. , Fischl M. , Goujard C. . & other authors ( 2012; ). Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study. . Clin Infect Dis 55:, 291–300. [CrossRef] [PubMed]
    [Google Scholar]
  132. Lewin S. R. , Evans V. A. , Elliott J. H. , Spire B. , Chomont N. . ( 2011; ). Finding a cure for HIV: will it ever be achievable?. J Int AIDS Soc 14:, 4. [CrossRef] [PubMed]
    [Google Scholar]
  133. Li Z. , Guo J. , Wu Y. , Zhou Q. . ( 2013; ). The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation. . Nucleic Acids Res 41:, 277–287. [CrossRef] [PubMed]
    [Google Scholar]
  134. Lusic M. , Marcello A. , Cereseto A. , Giacca M. . ( 2003; ). Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. . EMBO J 22:, 6550–6561. [CrossRef] [PubMed]
    [Google Scholar]
  135. Mansky L. M. , Temin H. M. . ( 1995; ). Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. . J Virol 69:, 5087–5094.[PubMed]
    [Google Scholar]
  136. Marcello A. . ( 2006; ). Latency: the hidden HIV-1 challenge. . Retrovirology 3:, 7.[PubMed] [CrossRef]
    [Google Scholar]
  137. Margolis L. , Shattock R. . ( 2006; ). Selective transmission of CCR5-utilizing HIV-1: the ‘gatekeeper’ problem resolved?. Nat Rev Microbiol 4:, 312–317.[PubMed] [CrossRef]
    [Google Scholar]
  138. Marini A. , Harper J. M. , Romerio F. . ( 2008; ). An in vitro system to model the establishment and reactivation of HIV-1 latency. . J Immunol 181:, 7713–7720.[PubMed] [CrossRef]
    [Google Scholar]
  139. Marsden M. D. , Zack J. A. . ( 2009; ). Eradication of HIV: current challenges and new directions. . J Antimicrob Chemother 63:, 7–10. [CrossRef] [PubMed]
    [Google Scholar]
  140. Mbonye U. , Karn J. . ( 2011; ). Control of HIV latency by epigenetic and non-epigenetic mechanisms. . Curr HIV Res 9:, 554–567. [CrossRef] [PubMed]
    [Google Scholar]
  141. McDonnel S. J. , Sparger E. E. , Luciw P. A. , Murphy B. G. . ( 2012; ). Pharmacologic reactivation of latent feline immunodeficiency virus ex vivo in peripheral CD4+ T-lymphocytes. . Virus Res 170:, 174–179. [CrossRef] [PubMed]
    [Google Scholar]
  142. McMahon D. , Jones J. , Wiegand A. , Gange S. J. , Kearney M. , Palmer S. , McNulty S. , Metcalf J. A. , Acosta E. . & other authors ( 2010; ). Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy. . Clin Infect Dis 50:, 912–919. [CrossRef] [PubMed]
    [Google Scholar]
  143. McNamara L. A. , Collins K. L. . ( 2011; ). Hematopoietic stem/precursor cells as HIV reservoirs. . Curr Opin HIV AIDS 6:, 43–48. [CrossRef] [PubMed]
    [Google Scholar]
  144. Middleton T. , Lim H. B. , Montgomery D. , Rockway T. , Tang H. , Cheng X. H. , Lu L. J. , Mo H. M. , Kohlbrenner W. E. , Molla A. . ( 2004; ). Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles. . Antiviral Res 64:, 35–45. [CrossRef] [PubMed]
    [Google Scholar]
  145. Mowat A. M. , Viney J. L. . ( 1997; ). The anatomical basis of intestinal immunity. . Immunol Rev 156:, 145–166. [CrossRef] [PubMed]
    [Google Scholar]
  146. Murphy B. , Vapniarsky N. , Hillman C. , Castillo D. , McDonnel S. , Moore P. , Luciw P. A. , Sparger E. E. . ( 2012; ). FIV establishes a latent infection in feline peripheral blood CD4+ T lymphocytes in vivo during the asymptomatic phase of infection. . Retrovirology 9:, 12. [CrossRef] [PubMed]
    [Google Scholar]
  147. Neal T. F. , Holland H. K. , Baum C. M. , Villinger F. , Ansari A. A. , Saral R. , Wingard J. R. , Fleming W. H. . ( 1995; ). CD34+ progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1. . Blood 86:, 1749–1756.[PubMed]
    [Google Scholar]
  148. Nicholson J. K. A. , Cross G. D. , Callaway C. S. , McDougal J. S. . ( 1986; ). In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). . J Immunol 137:, 323–329.[PubMed]
    [Google Scholar]
  149. North T. W. , Higgins J. , Deere J. D. , Hayes T. L. , Villalobos A. , Adamson L. , Shacklett B. L. , Schinazi R. F. , Luciw P. A. . ( 2010; ). Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS. . J Virol 84:, 2913–2922. [CrossRef] [PubMed]
    [Google Scholar]
  150. Novotney C. , English R. V. , Housman J. , Davidson M. G. , Nasisse M. P. , Jeng C. R. , Davis W. C. , Tompkins M. B. . ( 1990; ). Lymphocyte population changes in cats naturally infected with feline immunodeficiency virus. . AIDS 4:, 1213–1218. [CrossRef] [PubMed]
    [Google Scholar]
  151. O’Brien S. J. , Moore J. P. . ( 2000; ). The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. . Immunol Rev 177:, 99–111. [CrossRef] [PubMed]
    [Google Scholar]
  152. O’Doherty U. , Swiggard W. J. , Malim M. H. . ( 2000; ). Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. . J Virol 74:, 10074–10080. [CrossRef] [PubMed]
    [Google Scholar]
  153. Ostrowski M. A. , Chun T. W. , Justement S. J. , Motola I. , Spinelli M. A. , Adelsberger J. , Ehler L. A. , Mizell S. B. , Hallahan C. W. , Fauci A. S. . ( 1999; ). Both memory and CD45RA+/CD62L+ naive CD4+ T cells are infected in human immunodeficiency virus type 1-infected individuals. . J Virol 73:, 6430–6435.[PubMed]
    [Google Scholar]
  154. Oswald-Richter K. , Grill S. M. , Leelawong M. , Unutmaz D. . ( 2004; ). HIV infection of primary human T cells is determined by tunable thresholds of T cell activation. . Eur J Immunol 34:, 1705–1714. [CrossRef] [PubMed]
    [Google Scholar]
  155. Pace M. J. , Agosto L. , Graf E. H. , O’Doherty U. . ( 2011; ). HIV reservoirs and latency models. . Virology 411:, 344–354. [CrossRef] [PubMed]
    [Google Scholar]
  156. Palmer S. , Maldarelli F. , Wiegand A. , Bernstein B. , Hanna G. J. , Brun S. C. , Kempf D. J. , Mellors J. W. , Coffin J. M. , King M. S. . ( 2008; ). Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. . Proc Natl Acad Sci U S A 105:, 3879–3884. [CrossRef] [PubMed]
    [Google Scholar]
  157. Palmer S. , Josefsson L. , Coffin J. M. . ( 2011; ). HIV reservoirs and the possibility of a cure for HIV infection. . J Intern Med 270:, 550–560. [CrossRef] [PubMed]
    [Google Scholar]
  158. Parada C. A. , Roeder R. G. . ( 1996; ). Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. . Nature 384:, 375–378. [CrossRef] [PubMed]
    [Google Scholar]
  159. Pattanayak V. , Ramirez C. L. , Joung J. K. , Liu D. R. . ( 2011; ). Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. . Nat Methods 8:, 765–770. [CrossRef] [PubMed]
    [Google Scholar]
  160. Pedersen N. C. , Ho E. W. , Brown M. L. , Yamamoto J. K. . ( 1987; ). Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. . Science 235:, 790–793. [CrossRef] [PubMed]
    [Google Scholar]
  161. Peer D. , Karp J. M. , Hong S. , Farokhzad O. C. , Margalit R. , Langer R. . ( 2007; ). Nanocarriers as an emerging platform for cancer therapy. . Nat Nanotechnol 2:, 751–760. [CrossRef] [PubMed]
    [Google Scholar]
  162. Perez E. E. , Wang J. , Miller J. C. , Jouvenot Y. , Kim K. A. , Liu O. , Wang N. , Lee G. , Bartsevich V. V. . & other authors ( 2008; ). Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. . Nat Biotechnol 26:, 808–816. [CrossRef] [PubMed]
    [Google Scholar]
  163. Pérez-Martínez D. , Tanaka T. , Rabbitts T. H. . ( 2010; ). Intracellular antibodies and cancer: new technologies offer therapeutic opportunities. . Bioessays 32:, 589–598. [CrossRef] [PubMed]
    [Google Scholar]
  164. Pierson T. , Hoffman T. L. , Blankson J. , Finzi D. , Chadwick K. , Margolick J. B. , Buck C. , Siliciano J. D. , Doms R. W. , Siliciano R. F. . ( 2000; ). Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1. . J Virol 74:, 7824–7833. [CrossRef] [PubMed]
    [Google Scholar]
  165. Pierson T. C. , Zhou Y. , Kieffer T. L. , Ruff C. T. , Buck C. , Siliciano R. F. . ( 2002; ). Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. . J Virol 76:, 8518–8531. [CrossRef] [PubMed]
    [Google Scholar]
  166. Prins J. M. , Jurriaans S. , van Praag R. M. , Blaak H. , van Rij R. , Schellekens P. T. , ten Berge I. J. , Yong S. L. , Fox C. H. . & other authors ( 1999; ). Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy. . AIDS 13:, 2405–2410. [CrossRef] [PubMed]
    [Google Scholar]
  167. Ramratnam B. , Mittler J. E. , Zhang L. , Boden D. , Hurley A. , Fang F. , Macken C. A. , Perelson A. S. , Markowitz M. , Ho D. D. . ( 2000; ). The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. . Nat Med 6:, 82–85. [CrossRef] [PubMed]
    [Google Scholar]
  168. Reuse S. , Calao M. , Kabeya K. , Guiguen A. , Gatot J. S. , Quivy V. , Vanhulle C. , Lamine A. , Vaira D. . & other authors ( 2009; ). Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. . PLoS ONE 4:, e6093. [CrossRef] [PubMed]
    [Google Scholar]
  169. Richman D. D. , Margolis D. M. , Delaney M. , Greene W. C. , Hazuda D. , Pomerantz R. J. . ( 2009; ). The challenge of finding a cure for HIV infection. . Science 323:, 1304–1307. [CrossRef] [PubMed]
    [Google Scholar]
  170. Roesch F. , Meziane O. , Kula A. , Nisole S. , Porrot F. , Anderson I. , Mammano F. , Fassati A. , Marcello A. . & other authors ( 2012; ). Hyperthermia stimulates HIV-1 replication. . PLoS Pathog 8:, e1002792. [CrossRef] [PubMed]
    [Google Scholar]
  171. Rossi M. I. , Medina K. L. , Garrett K. , Kolar G. , Comp P. C. , Shultz L. D. , Capra J. D. , Wilson P. , Schipul A. , Kincade P. W. . ( 2001; ). Relatively normal human lymphopoiesis but rapid turnover of newly formed B cells in transplanted nonobese diabetic/SCID mice. . J Immunol 167:, 3033–3042.[PubMed] [CrossRef]
    [Google Scholar]
  172. Ruff C. T. , Ray S. C. , Kwon P. , Zinn R. , Pendleton A. , Hutton N. , Ashworth R. , Gange S. , Quinn T. C. . & other authors ( 2002; ). Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure. . J Virol 76:, 9481–9492. [CrossRef] [PubMed]
    [Google Scholar]
  173. Rullas J. , Bermejo M. , García-Pérez J. , Beltán M. , González N. , Hezareh M. , Brown S. J. , Alcamí J. . ( 2004; ). Prostratin induces HIV activation and downregulates HIV receptors in peripheral blood lymphocytes. . Antivir Ther 9:, 545–554.[PubMed]
    [Google Scholar]
  174. Sahu G. K. , Lee K. , Ji J. X. , Braciale V. , Baron S. , Cloyd M. W. . ( 2006; ). A novel in vitro system to generate and study latently HIV-infected long-lived normal CD4+ T-lymphocytes. . Virology 355:, 127–137. [CrossRef] [PubMed]
    [Google Scholar]
  175. Sahu G. K. , Paar D. , Frost S. D. W. , Smith M. M. , Weaver S. , Cloyd M. W. . ( 2009; ). Low-level plasma HIVs in patients on prolonged suppressive highly active antiretroviral therapy are produced mostly by cells other than CD4 T-cells. . J Med Virol 81:, 9–15. [CrossRef] [PubMed]
    [Google Scholar]
  176. Saleh S. , Solomon A. , Wightman F. , Xhilaga M. , Cameron P. U. , Lewin S. R. . ( 2007; ). CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency. . Blood 110:, 4161–4164. [CrossRef] [PubMed]
    [Google Scholar]
  177. Saleh S. , Wightman F. , Ramanayake S. , Alexander M. , Kumar N. , Khoury G. , Pereira C. , Purcell D. , Cameron P. U. , Lewin S. R. . ( 2011; ). Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells. . Retrovirology 8:, 80. [CrossRef] [PubMed]
    [Google Scholar]
  178. Schnittman S. M. , Psallidopoulos M. C. , Lane H. C. , Thompson L. , Baseler M. , Massari F. , Fox C. H. , Salzman N. P. , Fauci A. S. . ( 1989; ). The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. . Science 245:, 305–308. [CrossRef] [PubMed]
    [Google Scholar]
  179. Schröder A. R. , Shinn P. , Chen H. , Berry C. , Ecker J. R. , Bushman F. . ( 2002; ). HIV-1 integration in the human genome favors active genes and local hotspots. . Cell 110:, 521–529. [CrossRef] [PubMed]
    [Google Scholar]
  180. Scripture-Adams D. D. , Brooks D. G. , Korin Y. D. , Zack J. A. . ( 2002; ). Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype. . J Virol 76:, 13077–13082. [CrossRef] [PubMed]
    [Google Scholar]
  181. Shan L. , Deng K. , Shroff N. S. , Durand C. M. , Rabi S. A. , Yang H. C. , Zhang H. , Margolick J. B. , Blankson J. N. , Siliciano R. F. . ( 2012; ). Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. . Immunity 36:, 491–501. [CrossRef] [PubMed]
    [Google Scholar]
  182. Shen A. D. , Zink M. C. , Mankowski J. L. , Chadwick K. , Margolick J. B. , Carruth L. M. , Li M. , Clements J. E. , Siliciano R. F. . ( 2003; ). Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy. . J Virol 77:, 4938–4949. [CrossRef] [PubMed]
    [Google Scholar]
  183. Shimojima M. , Miyazawa T. , Ikeda Y. , McMonagle E. L. , Haining H. , Akashi H. , Takeuchi Y. , Hosie M. J. , Willett B. J. . ( 2004; ). Use of CD134 as a primary receptor by the feline immunodeficiency virus. . Science 303:, 1192–1195. [CrossRef] [PubMed]
    [Google Scholar]
  184. Siliciano, R. F. & Greene, W. C. (2011). HIV Latency. Cold Spring Harbor Perspectives in Medicine 1.
  185. Siliciano J. D. , Siliciano R. F. . ( 2010; ). Biomarkers of HIV replication. . Curr Opin HIV AIDS 5:, 491–497. [CrossRef] [PubMed]
    [Google Scholar]
  186. Siliciano J. D. , Kajdas J. , Finzi D. , Quinn T. C. , Chadwick K. , Margolick J. B. , Kovacs C. , Gange S. J. , Siliciano R. F. . ( 2003; ). Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. . Nat Med 9:, 727–728. [CrossRef] [PubMed]
    [Google Scholar]
  187. Sloan R. D. , Wainberg M. A. . ( 2011; ). The role of unintegrated DNA in HIV infection. . Retrovirology 8:, 52. [CrossRef] [PubMed]
    [Google Scholar]
  188. Stanley S. K. , Kessler S. W. , Justement J. S. , Schnittman S. M. , Greenhouse J. J. , Brown C. C. , Musongela L. , Musey K. , Kapita B. , Fauci A. S. . ( 1992; ). CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals. . J Immunol 149:, 689–697.[PubMed]
    [Google Scholar]
  189. Stevenson M. , Stanwick T. L. , Dempsey M. P. , Lamonica C. A. . ( 1990; ). HIV-1 replication is controlled at the level of T cell activation and proviral integration. . EMBO J 9:, 1551–1560.[PubMed]
    [Google Scholar]
  190. Svarovskaia E. S. , Barr R. , Zhang X. C. , Pais G. C. G. , Marchand C. , Pommier Y. , Burke T. R. Jr , Pathak V. K. . ( 2004; ). Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions. . J Virol 78:, 3210–3222. [CrossRef] [PubMed]
    [Google Scholar]
  191. Swan C. H. , Bühler B. , Tschan M. P. , Barbas C. F. , Torbett B. E . ( 2006; ). T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery. . Gene Ther 13:, 1480–1492. [CrossRef] [PubMed]
    [Google Scholar]
  192. Tobin N. H. , Learn G. H. , Holte S. E. , Wang Y. , Melvin A. J. , McKernan J. L. , Pawluk D. M. , Mohan K. M. , Lewis P. F. . & other authors ( 2005; ). Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus. . J Virol 79:, 9625–9634. [CrossRef] [PubMed]
    [Google Scholar]
  193. Tompkins M. B. , Tompkins W. A. . ( 2008; ). Lentivirus-induced immune dysregulation. . Vet Immunol Immunopathol 123:, 45–55. [CrossRef] [PubMed]
    [Google Scholar]
  194. Traggiai E. , Chicha L. , Mazzucchelli L. , Bronz L. , Piffaretti J. C. , Lanzavecchia A. , Manz M. G. . ( 2004; ). Development of a human adaptive immune system in cord blood cell-transplanted mice. . Science 304:, 104–107. [CrossRef] [PubMed]
    [Google Scholar]
  195. Trautmann L. , Janbazian L. , Chomont N. , Said E. A. , Gimmig S. , Bessette B. , Boulassel M.-R. , Delwart E. , Sepulveda H. . & other authors ( 2006; ). Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. . Nat Med 12:, 1198–1202. [CrossRef] [PubMed]
    [Google Scholar]
  196. Tyagi M. , Pearson R. J. , Karn J. . ( 2010; ). Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction. . J Virol 84:, 6425–6437. [CrossRef] [PubMed]
    [Google Scholar]
  197. Tzachanis D. , Lafuente E. M. , Li L. , Boussiotis V. A. . ( 2004; ). Intrinsic and extrinsic regulation of T lymphocyte quiescence. . Leuk Lymphoma 45:, 1959–1967. [CrossRef] [PubMed]
    [Google Scholar]
  198. Urnov F. D. , Miller J. C. , Lee Y.-L. , Beausejour C. M. , Rock J. M. , Augustus S. , Jamieson A. C. , Porteus M. H. , Gregory P. D. , Holmes M. C. . ( 2005; ). Highly efficient endogenous human gene correction using designed zinc-finger nucleases. . Nature 435:, 646–651. [CrossRef] [PubMed]
    [Google Scholar]
  199. Van Duyne R. , Pedati C. , Guendel I. , Carpio L. , Kehn-Hall K. , Saifuddin M. , Kashanchi F. . ( 2009; ). The utilization of humanized mouse models for the study of human retroviral infections. . Retrovirology 6:, 76. [CrossRef] [PubMed]
    [Google Scholar]
  200. van Grevenynghe J. , Procopio F. A. , He Z. , Chomont N. , Riou C. , Zhang Y. , Gimmig S. , Boucher G. , Wilkinson P. . & other authors ( 2008; ). Transcription factor FOXO3a controls the persistence of memory CD4+ T cells during HIV infection. . Nat Med 14:, 266–274. [CrossRef] [PubMed]
    [Google Scholar]
  201. van Leeuwen E. M. M. , Sprent J. , Surh C. D. . ( 2009; ). Generation and maintenance of memory CD4+ T cells. . Curr Opin Immunol 21:, 167–172. [CrossRef] [PubMed]
    [Google Scholar]
  202. Van Lint C. , Emiliani S. , Ott M. , Verdin E. . ( 1996; ). Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. . EMBO J 15:, 1112–1120.[PubMed]
    [Google Scholar]
  203. Vatakis D. N. , Bristol G. , Wilkinson T. A. , Chow S. A. , Zack J. A. . ( 2007; ). Immediate activation fails to rescue efficient human immunodeficiency virus replication in quiescent CD4+ T cells. . J Virol 81:, 3574–3582. [CrossRef] [PubMed]
    [Google Scholar]
  204. Vatakis D. N. , Kim S. , Kim N. , Chow S. A. , Zack J. A. . ( 2009; ). Human immunodeficiency virus integration efficiency and site selection in quiescent CD4+ T cells. . J Virol 83:, 6222–6233. [CrossRef] [PubMed]
    [Google Scholar]
  205. Vatakis D. N. , Nixon C. C. , Zack J. A. . ( 2010; ). Quiescent T cells and HIV: an unresolved relationship. . Immunol Res 48:, 110–121. [CrossRef] [PubMed]
    [Google Scholar]
  206. Verdin E. , Paras P. Jr , Van Lint C. . ( 1993; ). Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. . EMBO J 12:, 3249–3259.[PubMed]
    [Google Scholar]
  207. Volberding P. A. , Deeks S. G. . ( 2010; ). Antiretroviral therapy and management of HIV infection. . Lancet 376:, 49–62. [CrossRef] [PubMed]
    [Google Scholar]
  208. Wang F. X. , Xu Y. , Sullivan J. , Souder E. , Argyris E. G. , Acheampong E. A. , Fisher J. , Sierra M. , Thomson M. M. . & other authors ( 2005; ). IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. . J Clin Invest 115:, 128–137.[PubMed] [CrossRef]
    [Google Scholar]
  209. Weissman D. , Rabin R. L. , Arthos J. , Rubbert A. , Dybul M. , Swofford R. , Venkatesan S. , Farber J. M. , Fauci A. S. . ( 1997; ). Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. . Nature 389:, 981–985. [CrossRef] [PubMed]
    [Google Scholar]
  210. Wightman F. , Solomon A. , Khoury G. , Green J. A. , Gray L. , Gorry P. R. , Ho Y. S. , Saksena N. K. , Hoy J. . & other authors ( 2010; ). Both CD31+ and CD31⁻ naive CD4+ T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy. . J Infect Dis 202:, 1738–1748. [CrossRef] [PubMed]
    [Google Scholar]
  211. Wightman F. , Ellenberg P. , Churchill M. , Lewin S. R. . ( 2012; ). HDAC inhibitors in HIV. . Immunol Cell Biol 90:, 47–54. [CrossRef] [PubMed]
    [Google Scholar]
  212. Wilen C. B. , Wang J. , Tilton J. C. , Miller J. C. , Kim K. A. , Rebar E. J. , Sherrill-Mix S. A. , Patro S. C. , Secreto A. J. . & other authors ( 2011; ). Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases. . PLoS Pathog 7:, e1002020. [CrossRef] [PubMed]
    [Google Scholar]
  213. Willett B. J. , Picard L. , Hosie M. J. , Turner J. D. , Adema K. , Clapham P. R. . ( 1997; ). Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. . J Virol 71:, 6407–6415.[PubMed]
    [Google Scholar]
  214. Williams S. A. , Greene W. C. . ( 2007; ). Regulation of HIV-1 latency by T-cell activation. . Cytokine 39:, 63–74. [CrossRef] [PubMed]
    [Google Scholar]
  215. Williams S. A. , Kwon H. , Chen L. F. , Greene W. C. . ( 2007; ). Sustained induction of NF-κB is required for efficient expression of latent human immunodeficiency virus type 1. . J Virol 81:, 6043–6056. [CrossRef] [PubMed]
    [Google Scholar]
  216. Wolschendorf F. , Duverger A. , Jones J. , Wagner F. H. , Huff J. , Benjamin W. H. , Saag M. S. , Niederweis M. , Kutsch O. . ( 2010; ). Hit-and-run stimulation: a novel concept to reactivate latent HIV-1 infection without cytokine gene induction. . J Virol 84:, 8712–8720. [CrossRef] [PubMed]
    [Google Scholar]
  217. Wu Y. T. , Yoder A. . ( 2009; ). Chemokine coreceptor signaling in HIV-1 infection and pathogenesis. . PLoS Pathog 5:, e1000520. [CrossRef] [PubMed]
    [Google Scholar]
  218. Wu L. J. , Paxton W. A. , Kassam N. , Ruffing N. , Rottman J. B. , Sullivan N. , Choe H. , Sodroski J. , Newman W. . & other authors ( 1997; ). CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. . J Exp Med 185:, 1681–1692. [CrossRef] [PubMed]
    [Google Scholar]
  219. Xing S. , Bullen C. K. , Shroff N. S. , Shan L. , Yang H. C. , Manucci J. L. , Bhat S. , Zhang H. , Margolick J. B. . & other authors ( 2011; ). Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation. . J Virol 85:, 6060–6064. [CrossRef] [PubMed]
    [Google Scholar]
  220. Xing S. F. , Bhat S. , Shroff N. S. , Zhang H. , Lopez J. A. , Margolick J. B. , Liu J. O. , Siliciano R. F. . ( 2012; ). Novel structurally related compounds reactivate latent HIV-1 in a bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation. . J Antimicrob Chemother 67:, 398–403. [CrossRef] [PubMed]
    [Google Scholar]
  221. Yamamoto J. K. , Sparger E. , Ho E. W. , Andersen P. R. , O’Connor T. P. , Mandell C. P. , Lowenstine L. , Munn R. , Pedersen N. C. . ( 1988; ). Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. . Am J Vet Res 49:, 1246–1258.[PubMed]
    [Google Scholar]
  222. Yamamoto J. K. , Hansen H. , Ho E. W. , Morishita T. Y. , Okuda T. , Sawa T. R. , Nakamura R. M. , Pedersen N. C. . ( 1989; ). Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. . J Am Vet Med Assoc 194:, 213–220.[PubMed]
    [Google Scholar]
  223. Yang H. C. . ( 2011; ). Primary cell models of HIV latency. . Curr Opin HIV AIDS 6:, 62–67. [CrossRef] [PubMed]
    [Google Scholar]
  224. Yang H. C. , Xing S. F. , Shan L. , O’Connell K. , Dinoso J. , Shen A. D. , Zhou Y. , Shrum C. K. , Han Y. F. . & other authors ( 2009; ). Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. . J Clin Invest 119:, 3473–3486.[PubMed]
    [Google Scholar]
  225. Yeung F. , Hoberg J. E. , Ramsey C. S. , Keller M. D. , Jones D. R. , Frye R. A. , Mayo M. W. . ( 2004; ). Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. . EMBO J 23:, 2369–2380. [CrossRef] [PubMed]
    [Google Scholar]
  226. Ylisastigui L. , Archin N. M. , Lehrman G. , Bosch R. J. , Margolis D. M. . ( 2004; ). Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression. . AIDS 18:, 1101–1108. [CrossRef] [PubMed]
    [Google Scholar]
  227. Yoder A. , Yu D. Y. , Dong L. , Iyer S. R. , Xu X. H. , Kelly J. , Liu J. , Wang W. F. , Vorster P. J. . & other authors ( 2008; ). HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells. . Cell 134:, 782–792. [CrossRef] [PubMed]
    [Google Scholar]
  228. Yuan J. , Wang J. , Crain K. , Fearns C. , Kim K. A. , Hua K. L. , Gregory P. D. , Holmes M. C. , Torbett B. E. . ( 2012; ). Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4+ T cell resistance and enrichment. . Mol Ther 20:, 849–859. [CrossRef] [PubMed]
    [Google Scholar]
  229. Yukl S. A. , Shergill A. K. , McQuaid K. , Gianella S. , Lampiris H. , Hare C. B. , Pandori M. , Sinclair E. , Günthard H. F. . & other authors ( 2010; ). Effect of Raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy. . AIDS 24:, 2451–2460. [CrossRef] [PubMed]
    [Google Scholar]
  230. Yusuf I. , Fruman D. A. . ( 2003; ). Regulation of quiescence in lymphocytes. . Trends Immunol 24:, 380–386. [CrossRef] [PubMed]
    [Google Scholar]
  231. Zagury D. , Bernard J. , Leonard R. , Cheynier R. , Feldman M. , Sarin P. S. , Gallo R. C. . ( 1986; ). Long-term cultures of HTLV-III–infected T cells: a model of cytopathology of T-cell depletion in AIDS. . Science 231:, 850–853. [CrossRef] [PubMed]
    [Google Scholar]
  232. Zhou Y. , Zhang H. , Siliciano J. D. , Siliciano R. F. . ( 2005; ). Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells. . J Virol 79:, 2199–2210. [CrossRef] [PubMed]
    [Google Scholar]
  233. Zhu T. , Mo H. , Wang N. , Nam D. S. , Cao Y. , Koup R. A. , Ho D. D. . ( 1993; ). Genotypic and phenotypic characterization of HIV-1 patients with primary infection. . Science 261:, 1179–1181. [CrossRef] [PubMed]
    [Google Scholar]
  234. Zhu J. , Gaiha G. D. , John S. P. , Pertel T. , Chin C. R. , Gao G. , Qu H. , Walker B. D. , Elledge S. J. , Brass A. L. . ( 2012; ). Reactivation of latent HIV-1 by inhibition of BRD4. . Cell Rep 2:, 807–816. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.049296-0
Loading
/content/journal/jgv/10.1099/vir.0.049296-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error